POTOMAC, Md., June 30, 2011 /PRNewswire/ — The Chinese
Biopharmaceutical Association-USA (CBA) successfully held its
16th Annual Conference on June 26 in Maryland, US.
With the theme of From Personal Genomes to
Translational Medicine, the conference drew nearly 500
attendees with more than 30 distinguished speakers. Many sponsors
supported and exhibited at the conference, including Chinese
leading biotech parks, international pharmaceutical and biotech
companies, US and Chinese government agencies, and international
non-profit organizations.
Mr. Xiongfeng Chen, Counselor and Consul General of the Embassy
of People’s Republic of China in the USA, attended the conference.
In his opening remarks, Mr. Chen recognized CBA’s
contributions in promoting scientific communications and
collaborations between the US and China, and encouraged the CBA to
continue to serve as a bridge between the US and Chinese
biopharmaceutical industries. He noted that China will spend $308
billion on science and technology by the end of 2015, and he
believes the vast investment will further enhance scientific
collaboration between the US and China.
During the conference, Zhifeng Long, PhD, CBA president
(2011-2012), chairperson of the conference organizing committee,
presented 2011 CBA Brilliant Achievement Award to Mr. Thomas
Watkins, President and CEO, Human Genome Sciences Inc, and Jonathan
M. Rothberg, PhD, Founder, CEO and Chairman, Ion Torrent
Corporation, in recognition of their seminal contributions to
science, technology or business development in the
biopharmaceutical fields, and their efforts in promoting public
awareness of the importance of collaborations between basic and
applied researchers, between academia and industry, and between
researchers and entrepreneurs.
Dr Long also presented the 2011 CBA Outstanding Public
Service Award to Yuling Li, PhD, former CBA president
(2007-2008),
‘/>”/>
